CRRT 2004 Syllabus Contents
Friday Morning, February 27, 2004
SESSION I: PATIENT CHARACTERISTICS
7:30-9:45 MINI-SYMPOSIA:
Multi-Organ DysfunctionSyndrome (MODS)
Co-Chairs: Noel Gibney, MD
William Macias, MD PhD
7:30-7:50 Epithelial Dysfunction:
The Common Denominator of MODS?
Mitchell Fink, MD
7:50-8:10 Heart Failure
Thomas Heywood, MD
8:10-8:30 Hepatic Failure
Tarek Hassanein, MD
8:30-8:50 Gentotypes and Phenotypes: The Sepsis Story
John Kellum, MD
8:50-9:10 Pathophysiology Post-trauma
David B. Hoyt, MD
9:10-9:30 Coagulation Abnormalities in Sepsis
Jean Francis Dhainaut, MD
9:30-9:45 Panel Discussion
Moderator: Patrick Murray, MD
Jean Francois Dhainaut, MD
Mitchell Fink, MD
Noel Gibney, MD
Tarek Hassanein, MD
Thomas Heywood, MD
David Hoyt, MD
John Kellum, MD
William Macias, MD PhD
SESSION I: PATIENT CHARACTERISTICS
10:00-12:00 MINI-SYMPOSIA:
Controversies in Management of the Critically Ill Patient: Resuscitation
Co-Chairs: Patrick Honore, MD
Martine Leblanc, MD FRCPc
10:00-10:20 Small Volume Resuscitation
David B. Hoyt, MD
10:20-10:40 Goal-directed Resuscitation: What Targets?
Mitchell Fink, MD
10:40-11:00 Improving Organ Function:
Strategies for Management Post-cardiac Arrest
Jean Francois Dhainaut, MD
11:00-11:20 Hematological Support
Miet Schetz, MD PhD
11:20-11:40 Vasopressors and Ionotropes: Choices and Strategies
Patrick T. Murray, MD
11:40-12:00 Panel Discussion
Moderator: John Kellum, MD
Jean Francois Dhainaut, MD
Mitchell Fink, MD
Patrick Honore, MD
David Hoyt, MD
Martine Leblanc, MD FRCPc
Patrick Murray, MD
Miet Schetz, MD PhD
Friday Afternoon, February 27, 2004
SIMULTANEOUS SESSION FOR NURSING AND ALLIED PERSONNEL
1:00-2:30 MINI SYMPOSIA:
Minimizing Iatrogenic Complications in the Patient with Renal Failure
Co-Chairs: Marie Pascual, RN BSN MPH
Christine Gassensmith, RN
1:00-1:15 Preventing Intradialytic Hypotension
Patrick T. Murray, MD
1:15-1:30 Drug Interactions and Their Management
Bruce Mueller, PharmD FCCP
1:30-1:45 Infection Control for Central Lines
Maria Pascual, RN BSN MPH
1:45-2:00 Recognizing and Treating Complications in CRRT
Ian Baldwin, RN MN ACCCN
2:00-3:30 Panel Discussion
Moderator: Patti Graham, RN
Ian Baldwin, RN ACCN
Christine Gassensmith, RN
Bruce Mueller, PharmD FCCP
Patrick Murray, MD
Maria Pascual, RN BSN MPH
SESSION II: EMERGING CONCEPTS IN ARF AND CRRT
2:45-5:15 MINI-SYMPOSIA:
Can We Change the Course of Acute Renal Failure?
Co-chairs: Jean Francois Dhainaut, MD
H. David Humes, MD
2:45- 3:05 Acute Renal Failure: Targets for Intervention
Joseph V. Bonventre, MD PhD
3:05- 3:25 Distant Effects of ARF: How the Kidney Talks to Other Organs
Katherine J. Kelly, MD
3:25- 3:45 Lessons from Sepsis: The Role of ARF
William L. Macias, MD PhD
3:45- 4:05 Renal Function Preservation: The Role of Diuretics
Ravindra L. Mehta, MD
4:05- 4:25 Outcomes from ARF: What Constitutes Success?
Glenn M. Chertow, MD MPH
4:25-4:45 Emerging Strategies: Anti-inflammatory Agents for ARF
Mitchell Fink, MD
4:45-5:15 Panel Discussion
Moderator: Claudio Ronco, MD
Joseph Bonventre, MD PhD
Glenn Chertow, MD MPH
Jean Francois Dhainaut, MD
Mitchell Fink, MD
H. David Humes, MD
Katherine Kelly, MD
William Macias, MD PhD
Ravindra Mehta, MD
Saturday Morning, February 28, 2004
SESSION III: TECHNIQUE CHARACTERIstics
8:00-10:30 MINI-SYMPOSIA:
Controversies in RRT: Increasing the Dose of CRRT
Co-Chairs: William Clark, MD
Miet Schetz, MD PhD
8:00-8:15 Enhancing the Dose in CRRT: The Role of Membrane and Blood Flow
Michael Kraus, MD
8:15-8:30 Pre-dilution vs Post-dilution Replacement for CRRT:
Does it Matter?
Andrew Davenport, MD FRCP
8:30-8:45 Thermal Balance: Complications or Therapeutic Tool?
Claudio Ronco, MD
8:45-9:00 Is "High Dose" Hemofiltration Attainable in Children?
Timothy E. Bunchman, MD
9:00-9:15 Influence of Dose Delivery on Drug and Nutritional Therapy
Bruce Mueller, Pharm D FCCP
9:15-9:45 Debate
Dialysis Dose in ARF: More is Better
Pro: Claudio Ronco, MD
Con: Emil Paganini, MD
9:45-10:15 Panel Discussion
Moderator: Thomas Golper, MD
Timothy Bunchman, MD
William Clark, MD
Andrew Davenport, MD FRCP
Michael Kraus, MD
Bruce Mueller, PharmD FCCP
Emil Paganini, MD
Claudio Ronco, MD
Miet Schetz, MD PhD
SESSION III: TECHNIQUE CHARACTERISTICS
10:30-12:30 SPECIAL SESSION:
Applications for CRRT: What's New?
Co-Chairs: Michael Kraus, MD
Andre Kaplan, MD
10:30-10:50 High Volume and High Permeability Hemofiltration fo Sepsis:
The Evidence and the Key Issues
Patrick Honore, MD
10:50-11:10 The Bio-engineered Kidney: Therapy for Septic Shock?
H. David Humes, MD
11:10-11:30 Can CRRT Prevent Contrast Nephropathy?
Noel Gibney, MD
11:30-11:50 Ultrafiltration for Heart Failure
Geoffrey Sheinfeld, MD
11:50-12:05 ADQI Update
John Kellum, MD
12:05-12:30 Panel Discussion
Moderator: Emil Paganini, MD
Noel Gibney, MD
Patrick Honore, MD
H. David Humes, MD
Andre Kaplan, MD
John Kellum, MD
Michael Kraus, MD
Geoffrey Sheinfeld, MD
Saturday Afternoon, February 28, 2004
SIMULTANEOUS SESSION FOR NURSING AND ALLIED PERSONNEL
1:30-3:00 MINI-SYMPOSIA:
The Year in Review: What You Should Know and Care About
Co-Chairs: Barbra Alan, RN CNN
Bruce Mueller, PharmD FCCP
1:30-1:50 Critical Care Nephrology
Jorge Cerda, MD
1:50-2:10 Nursing
Rhonda Martin, RN MS CNS/ACNP-C
2:10-2:30 Nutrition
Bruce Mueller, Pharm D FCCP
2:30-2:50 Management of Sepsis
Noel Gibney, MD
2:50-3:00 Panel Discussion
Moderator: Rhonda Martin, RN MS CNS/ACNP-C
Barbra Alan, RN CNN
Jorge Cerda, MD
Noel Gibney, MD
Bruce Mueller, PharmD FCCP
SESSION IV: FUTURE TRENDS IN CRRT
3:15-5:00 MINI-SYMPOSIA:
Looking to the Future: What Can We Expect?
Co-Chairs: Steven Alexander, MD
Jorge Cerda, MD
3:15-3:35 Early Diagnosis of ARF: Emerging Techniques
Joseph V. Bonventre, MD PhD
3:35-3:55 Novel Treatments for ARF: The Case for Combination Therapies
Katherine J. Kelly, MD
3:55-4:15 Sharing Information: The Role of Registries
Stuart Goldstein, MD
4:15-4:35 Cell Therapy: Leveraging Nature's Therapeutic Potential
H. David Humes, MD
4:35-5:00 Panel Discussion
Moderator: Timothy Bunchman, MD
Steven Alexander, MD
Joseph Bonventre, MD PhD
Jorge Cerda, MD
Stuart Goldstein, MD
H. David Humes, MD
Katherine Kelly, MD
Workshops
Thusday, February 26, 2004
A01 CRRT Systems I (I)
I. Fresenius Systems
Christian Schlaeper
II. Baxter ACCURA System
Lee Ware
B02 Vascular Access, Membrane and Circuit (C)
Catheter choice, placement, maintenance, recognition and management of complcations, selection and
use of membranes for different applications, circuit design, setup and monitoring.
Ian Baldwin, RN ACCCN
Michael Kraus, MD
C03 Dialysis Dose Prescription and Delivery with Dialytic Techniques (I)
Operational characteristics influencing solute removal in IHD, PD and CRRT.
William R. Clark, MD
Claudio Ronco, MD
D04 Drug Management (I)
Practical issues for developing and implementing policies and protocols for CRRT.
Thomas Golper, MD
Bruce Mueller, PharmD FCCP
E05 CRRT Around the World: Clinical Vignettes (I)
Illustrative cases demonstrating applications of CRRT in various settings
Andrew Davenport, MD FRCP
Hiroyuki Hirasawa, MD PhD
Martine Leblanc, MD FRCPc
Geoffrey Sheinfeld, MD
Miet Schetz, MD, PhD
F06 Experimental Models for Sepsis, ARF and CRRT (I)
Description of animal and in-vivo models for anti-renal failure, sepsis and CRRT
technique including components for new therapeutics (membrane circuits)
Patrick Honore, MD
Joseph Bonventre, MD PhD
John Kellum, MD
G07 Cancelled
SIMULTANEOUS WORKSHOPS
GROUP 2
(repeated in Group 5)
A08 CRRT Systems II (I)
I. Edwards Critical Care Aquarius
Bev Ryan, RN
II. NxStage Therapy System
William Clark, MD
Karen Schardin
B09 Anticoagulation in CRRT (C)
Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation
Andrew Davenport, MD
Noel Gibney, MD
Thomas Golper, MD
C10 Fluid Management (I,N,AP)
Principles of volume assessment management with different CRRT equipment.
Ravindra L. Mehta, MD
Miet Schetz, MD PhD
D11 Practical Aspects for Running a CRRT Program (I, N, AP)
Practical issues for developing and implementing policies and protocols for CRRT
Jorge Cerda, MD
Emil Paganini, MD
Rhonda K. Martin, RN, MS, CNS/ACNP-C
E12 The Patient with Cardiac and Renal Failure: Emerging Therapies (I,N,AP) (SCIOS Workshop)
Pathophysiology, recognition and management strategies for cardiac and
renal failure in the critically ill patient
Thomas Heywood, MD
Geoffrey Sheinfeld, MD
Vandana Mathur, MD
F13 Clinical Research in the ICU 1: Clinical Trial Design (I,N,AP)
Information from published and ongoing studies will be used to illustrate key concepts of study design
for clinical trials in the ICU with a focus on design issues that influence the likelihood of success.
Glenn Chertow, MD MPH
Jean Francois Dhainaut, MD
William Macias, MD PhD
Patrick Murray, MD
G14 Basics of Pediatric CRRT (I,N,AP) Not repeated
Technique requirement and application for use in children including neonates
Timothy Bunchman, MD (Moderator)
Steven Alexander, MD
Patrick Brophy, MD
Jason Foland, MD
Stuart Goldstein, MD
SIMULTANEOUS WORKSHOPS
GROUP 3
(repeated in Group 6)
A15 CRRT Systems III (I)
I.Gambro Prisma
Stacey Johnson, RN CNN
II.B. Braun Diapact
Anthony Annone
B16 Solutions for CRRT (A)
Basic concepts for formulation and application in critically ill patients.
Patrick Brophy, MD
Timothy Bunchman, MD
Richard Swartz, MD
Sheldon Tobe, MD FRCP(C)
C17 Nutritional Assessment and Support (I)
Principles of nutritional assessment and management in ARF and CRRT
Martine Leblanc, MD FRCPc
D18 Plasma Exchange Therapy for the Critically Ill Patient (I, N, AP)
Techniques, patient selection and applications
Andre Kaplan, MD
David Ward, MD
E19 Therapy Comparisons: SLED vs CRRT
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
Ian Baldwin, RN ACCCN
William Clark, MD
Maureen Craig, RN MSN CNN CCNS
Thomas Golper, MD
F20 Clinical Research in the ICU II: Study Implementation (I, N, AP)
Practical aspects of conducting a clinical trial in the ICU including development of a protocol, database, budgeting, nursing requirements, IRB and regulatory issues, consents from surrogates, and study implementation
Christine Gassensmith, RN
Maria Pascual, RN BSN MPH
Sandra Woods, RN
G21 Nursing Issues in Pediatric CRRT (C,N,AP) (not repeated)
Circuit protocol policy for pediatric CRRT
Steven Alexander, MD (Moderator)
Timothy Bunchman, MD
Helen Currier, RN BSN CNN
John Gardner, RN BSN
SIMULTANEOUS WORKSHOPS
GROUP 4
(Repeat of Group 1)
A22 CRRT Systems I (I)
I. Fresenius Systems
Christian Schlaeper
II. Baxter ACCURA System
Lee Ware
B23 Vascular Access, Membrane and Circuit (C)
Catheter choice, placement, maintenance, recognition and management of complcations, selection and use of membranes for different applications, circuit design, setup and monitoring.
Ian Baldwin, RN ACCCN
Michael Kraus, MD
C24 Dialysis Dose Prescription and Delivery with Dialytic Techniques (I)
Operational characteristics influencing solute removal in IHD, PD and CRRT.
William R. Clark, MD
Claudio Ronco, MD
D25 Drug Management (I)
Practical issues for developing and implementing policies and protocols for CRRT.
Thomas Golper, MD
Bruce Mueller, PharmD FCCP
E26 CRRT Around the World: Clinical Vignettes (I)
Illustrative cases demonstrating applications of CRRT in various settings
Andrew Davenport, MD FRCP
Hiroyuki Hirasawa, MD PhD
Martine Leblanc, MD FRCPc
Geoffrey Sheinfeld, MD
Miet Schetz, MD, PhD
F27 Experimental Models for Sepsis, ARF and CRRT (I)
Description of animal and in-vivo models for anti-renal failure, sepsis and CRRT technique including components for new therapeutics (membrane circuits)
Patrick Honore, MD
Joseph Bonventre, MD PhD
John Kellum, MD
G28 Cancelled
SIMULTANEOUS WORKSHOPS
GROUP 5
Repeat of Group 2, except G35)
A29 CRRT Systems II (I)
I. Edwards Critical Care Aquarius
Bev Ryan, RN
II. NxStage Therapy System
William Clark, MD
Karen Schardin
B30 Anticoagulation in CRRT (C)
Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation
Andrew Davenport, MD
Noel Gibney, MD
Thomas Golper, MD
C31 Fluid Management (I,N,AP)
Principles of volume assessment management with different CRRT equipment.
Ravindra L. Mehta, MD
Miet Schetz, MD PhD
D32 Practical Aspects for Running a CRRT Program (I, N, AP)
Practical issues for developing and implementing policies and protocols for CRRT
Jorge Cerda, MD
Emil Paganini, MD
Rhonda K. Martin, RN, MS, CNS/ACNP-C
E33 The Patient with Cardiac and Renal Failure:
Emerging Therapies (I,N,AP) (SCIOS Workshop)
Pathophysiology, recognition and management strategies for cardiac and renal failure in the critically ill patient
Thomas Heywood, MD
Geoffrey Sheinfeld, MD
Vandana Mathur, MD
F34 Clinical Research in the ICU 1: Clinical Trial Design (I,N,AP)
Information from published and ongoing studies will be used to illustrate key concepts of study design for clinical trials in the ICU with a focus on design issues that influence the likelihood of success.
Glenn Chertow, MD MPH
Jean Francois Dhainaut, MD
William Macias, MD PhD
Patrick Murray, MD
G35 Pediatric CRRT Complications: Case Studies (I, N, AP) (Not repeated)
Case based discussion of common problems seen in pediatric CRRT and strategies for management.
Steven Alexander, MD (moderator)
Timothy Bunchman, MD
Patrick Brophy, MD
Jason Foland, MD
Stuart Goldstein, MD
SIMULTANEOUS WORKSHOPS
GROUP 6
(Repeat of Group 3, except G42)
A36 CRRT Systems III (I)
I. Gambro Prisma
Stacey Johnson, RN CNN
II. B. Braun Diapact
Anthony Annone
B37 Solutions for CRRT (A)
Basic concepts for formulation and application in critically ill patients.
Patrick Brophy, MD
Timothy Bunchman, MD
Richard Swartz, MD
Sheldon Tobe, MD FRCP(C)
C38 Nutritional Assessment and Support (I)
Principles of nutritional assessment and management in ARF and CRRT
Martine Leblanc, MD FRCPc
D39 Plasma Exchange Therapy for the Critically Ill Patient (I, N, AP)
Techniques, patient selection and applications
Andre Kaplan, MD
David Ward, MD
E40 Therapy Comparisons: SLED vs CRRT
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
Ian Baldwin, RN ACCCN
William Clark, MD
Maureen Craig, RN MSN CNN CCNS
Thomas Golper, MD
F41 Clinical Research in the ICU II: Study Implementation (I, N, AP)
Practical aspects of conducting a clinical trial in the ICU including development of a protocol, database, budgeting, nursing requirements, IRB and regulatory issues, consents from surrogates, and study implementation
Christine Gassensmith, RN
Maria Pascual, RN BSN MPH
Sandra Woods, RN
G42 The Pediatric CRRT Multi-center Database (I,N,AP) (Not repeated)
Discussion of the key findings from the pediatric multicenter database on CRRT and its application for clinical practice
Stuart Goldstein, MD (Moderator)
Helen Currier, RN BSN CNN
Patrick Brophy, MD
Jason Foland, MD
return
|
